4.6 Review Book Chapter

Adhesion G Protein-Coupled Receptors as Drug Targets

Journal

Publisher

ANNUAL REVIEWS
DOI: 10.1146/annurev-pharmtox-010617-052933

Keywords

therapeutic; agonist; antagonist; ligand; antibody; pharmaceutical

Funding

  1. NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS094136] Funding Source: NIH RePORTER
  2. NINDS NIH HHS [R21 NS094136, R01 NS072394] Funding Source: Medline

Ask authors/readers for more resources

The adhesion G protein-coupled receptors (aGPCRs) are an evolutionarily ancient family of receptors that play key roles in many different physiological processes. These receptors are notable for their exceptionally long ectodomains, which span several hundred to several thousand amino acids and contain various adhesion-related domains, as well as a GPCR autoproteolysis-inducing (GAIN) domain. The GAIN domain is conserved throughout almost the entire family and undergoes autoproteolysis to cleave the receptors into two noncovalently-associated protomers. Recent studies have revealed that the signaling activity of aGPCRs is largely determined by changes in the interactions among these protomers. We review recent advances in understanding aGPCR activation mechanisms and discuss the physiological roles and pharmacological properties of aGPCRs, with an eye toward the potential utility of these receptors as drug targets.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available